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and upcoming bimonthly publicationNearly 2 years have passed since the Japanese Respiratory
Society (JRS) launched its ofﬁcial English journal, Respiratory
Investigation. Already, 199 papers have been submitted to the
journal, and 79 papers have been accepted. Sixty-seven articles
were published in 2012 and 2013. The Editor-in-Chief and
Associate Editors would like to express our appreciation for
the authors who have submitted their papers to this relatively
new journal. We also express our sincere gratitude to the 271
reviewers for spending their time reading and evaluating these
manuscripts. In total, we have published 5 reviews, 32 original
papers, 9 case reports, 2 guidelines and statements, 1 short
communication, and 8 editorials. In the topics series on
Respiratory Medicine during the Great East Japan Earthquake
and Tsunami, we published 2 reviews and 8 articles, which
included case reports. Because the journal is not yet well-
known in the greater Asia region and worldwide, the manu-
scripts received thus far are primarily from Japan. Only a few
manuscripts were submitted from researchers overseas, and
those were not deemed acceptable. In time, we expect more
submissions from researchers all over the world.
We have published several review articles on topics origi-
nating from Japan. One example is a review on the biomarker
KL-6/MUC1, which is derived from type II pneumocytes
in interstitial lung diseases such as IPF, hypersensitivity
pneumonitis, and acute interstitial pneumonia [1]. Another
review discussed the unique research on Propionibacterium
acnes as an etiologic link to sarcoidosis [2]. In addition, 2
guidelines were translated from Japanese; one was an excerpt
statement written by the JRS committee, and discussed the
diagnosis and treatment of drug-induced pulmonary injury,
which is now recognized to have a relatively high incidence
among the Japanese population [3]. These articles were
selected as the Editor's Choice, and readers are generally
allowed free access to these articles. Among the original
articles is an investigation of severe pneumonia caused by
avian inﬂuenza A (H5N1), published collaboratively by groups
based in Vietnam and Japan [4]. Several clinical trials were also
published as original articles in Respiratory Investigation. We
continue to encourage authors to submit case reports with
more than 2 cases in order to facilitate investigations into the
underlying disease pathology. The topics series on respiratory
medicine during the Japan Tsunami Disaster in 2011 high-
lighted a wide range of unique medical problems both during
the tsunami itself, as well as during the recovery period.Y-NC-ND license.As the Editor-in-Chief of the ofﬁcial English journal from
the Japanese Respiratory Society, I am well aware of the
difﬁculties faced by Japanese and other Asian authors while
writing manuscripts in English. These difﬁculties are not
merely a problem of writing in the English language; they
also arise from the different cultural backgrounds and the
lack of education on western logical thinking. In this editorial,
I will brieﬂy discuss some of the problems that authors face
when writing an English manuscript, especially in Asia, and
suggest possible solutions. I have worked with many doctors
from overseas during their graduate course training in
Tohoku University, with 10 of them from Asian countries
and I greatly enjoyed the experience. Through their talented
work, I could see how these countries will achieve both
economic and academic development in 21st century. How-
ever, I could also see that writing an English manuscript was
still a tough task in these non-English speaking countries,
although the situation has rapidly improved due to recent
economic success, exposure to international television
media, and the internet.
I myself learned the logical thinking required to write and
submit English manuscripts while working at the National
Institutes of Health (NIH), located in Bethesda, MD, USA for 4
years. When I returned to Japan and began working at
Juntendo University in Tokyo in the late 1980s, I transferred
the knowledge gained at the NIH to instruct young Japanese
doctors on writing English manuscripts. Through this experi-
ence, I was able to recognize the cultural differences that
made it difﬁcult for authors from non-English speaking
countries to write manuscripts in the western logic, espe-
cially in laying out a logical scenario and composing it into a
manuscript. “Globalization by western logic” is a current key
phrase for business people in Asia, but logical communica-
tion or debates in Asian academia will require further train-
ing. We traditionally do not truly learn how to persuade
colleagues or friends to understand our presentation. We do
not have “Show and Tell” presentations in primary schools in
Japan. During my time at the NIH, for instance, my mentor
would repeatedly ask me “What is your message?” When
Asian young doctors succeed in their pilot experiments, they
need to be able to discuss the images and ﬁnal ﬁgures in the
logical development of their manuscripts. This training
should be guided by instructors who have learned western
logic in the United States or in European countries.
E d i t o r i a l / r e s p i r a t o r y i n v e s t i g a t i o n 5 2 ( 2 0 1 4 ) 1 – 22In addition to discussing the ﬁgures in experimental or
in vitro studies, current rules for clinical studies in medical
journals require study protocol approval by the Institutional
Review Board (IRB). This is required even for retrospective
studies because of the use of medical records. Inclusion of
informed consent from patients or healthy volunteers in the
clinical study protocol will be an indispensable requirement
for the submission of manuscripts for clinical trials. Japanese
academic institutions and local general hospitals have gra-
dually incorporated these guidelines for clinical trials in the
last 10 years. Greater awareness of the requirements for
clinical studies will promote further clinical investigation in
Asian countries and will provide valuable ﬁndings.
Finally, it is our great pleasure to inform you that our
journal is moving to a bimonthly publication model. The
increased publication frequency will provide earlier exposure
of exciting work to our readers and increase the number of
published articles by 50%. The editorial ofﬁce of the Respira-
tory Investigation welcomes the continued submission of
your manuscripts in the areas of pulmonary biology and
respiratory medicine.r e f e r e n c e s
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